2019 China-Japan Advanced Medical and New Drug R&D Summit Forum and Achievement Transformation Conference held in Sichuan

On November 10, 2019 China Japan advanced medical and new drug R & D summit and achievement transformation conference were held in Chengdu, Sichuan Province Academicians and experts from China and Japan gathered together to share and exchange cutting-edge information and development trend of biomedical industry He Wei, vice chairman of the CPPCC National Committee, Yin Li, deputy secretary of the CPC Provincial Committee and governor of the province, Jiao Hong, director of the State Drug Administration, and TATO Sato, director of the comprehensive agency of pharmaceutical medical devices, an independent administrative legal person, attended the opening ceremony of the conference and delivered speeches He Wei congratulated the General Assembly on its opening He said that since the beginning of the 21st century, biotechnology has made continuous breakthroughs, which not only supports the development of life science, but also promotes the rapid development of biomedical industry Promoting human health is the fundamental direction and important task of the development of biomedical industry; strengthening scientific and technological innovation is an important driving force for the development of biomedical industry; promoting win-win cooperation is the path guarantee for the development of biomedical industry Japan will bring 400 advanced medical technologies and biomedical products into clinical research for exhibition and transformation, and China will also provide more than 500 cutting-edge technological achievements, which will surely contribute to deepening cooperation, improving efficiency of achievements transformation and expanding medical industry cluster of both sides It is hoped that both sides will seize this important opportunity and strive to promote the realization of biomedical industry in both countries Complementary industrial advantages and win-win cooperation Yin Li, on behalf of the provincial government, congratulated the convening of the conference He said that the conference has built a platform for top experts and scholars in the industry to exchange ideas and gather wisdom, set up a bridge for well-known enterprises at home and abroad to strengthen docking and deepen cooperation, and will certainly contribute to the healthy development of the global pharmaceutical industry and the comprehensive development of medical services We are very willing to listen to the opinions and suggestions of all participants, learn from the advanced experience of Japanese pharmaceutical innovation and achievements transformation, and strengthen technical exchanges and industrial docking We sincerely welcome experts to come to Sichuan to carry out academic exchanges, and provide more valuable suggestions and guidance for the innovation and development of Sichuan pharmaceutical industry We sincerely hope that all entrepreneurs will come to Sichuan to investigate, discuss, invest and develop, share the development opportunities of Sichuan pharmaceutical industry, and create a healthy and bright future for all Jiao Hong, on behalf of the State Drug Administration, congratulated the convening of the conference She said that in recent years, research and development of advanced medical products such as cell therapy, gene therapy and tissue engineering have become one of the most important frontier areas of international medicine It is believed that this conference will further promote the cooperation between China and Japan in the pharmaceutical industry and promote the landing and transformation of more high-quality pharmaceutical achievements It is hoped that more scientific research institutions and pharmaceutical enterprises will promote the R & D and application of new technologies and products, provide more and better innovative drugs for the people and promote the high-quality development of China's pharmaceutical industry through the international exchange and achievement display platform set up by the conference On behalf of Japan's independent administrative legal person medical products and medical devices Bureau, TATO Sato congratulated the conference and expressed his willingness to work hard to promote the unity and cooperation of production, education and research between China and Japan, work together to overcome the problems of advanced medical and new drug research and development, and better benefit the people Luo Qiang, mayor of Chengdu, and Fukushima Athens, director of Kobe transformation medical research center, respectively delivered speeches Speech by Ben Shuyou, winner of the 2018 Nobel Prize in physiology or medicine At the opening ceremony, the launch ceremony of "China Japan biomedical achievement transformation express" was also held, and the representatives of China Japan biomedical enterprises signed the achievement transformation strategic cooperation agreement Chen Fang, vice chairman of the CPPCC Provincial Committee, representatives of Chinese and Japanese scientific research institutes, industrial parks, business associations, enterprises and heads of relevant provincial departments attended the conference Penicillin